Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Hiltbrunner, S; Britschgi, C; Schuberth, P; Bankel, L; Nguyen-Kim, T D L; Gulati, P; Weder, W; Opitz, I; Lauk, O; Caviezel, C; Bachmann, H; Tabor, A; Schröder, P; Knuth, A; Münz, C; Stahel, R; Boyman, O; Renner, C; Petrausch, U; Curioni-Fontecedro, A (2021). Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial. Annals of Oncology, 32(1):120-121.

Additional indexing

Item Type:	Journal Article, refereed, original work
Communities & Collections:	04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology 04 Faculty of Medicine > University Hospital Zurich > Clinic for Thoracic Surgery 04 Faculty of Medicine > Institute of Experimental Immunology 04 Faculty of Medicine > University Hospital Zurich > Clinic for Immunology
Dewey Decimal Classification:	610 Medicine & health
Language:	English
Date:	1 January 2021
Deposited On:	15 Dec 2020 17:00
Last Modified:	22 Jun 2025 01:42
Publisher:	Oxford University Press
ISSN:	0923-7534
OA Status:	Hybrid
Free access at:	Publisher DOI. An embargo period may apply.
Publisher DOI:	https://doi.org/10.1016/j.annonc.2020.10.474
PubMed ID:	33098996